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Background: Cervical cancer is one of the commonest causes of cancer-related deaths worldwide. The prevalence
rate of cervical cancer in Uyghur women in Xinjiang Autonomous Region of China has been remarkably higher than
the ethnic groups living in the same region. This study aimed to assess the knowledge level and attitude of cervical
cancer and its issues among the Uyghur women in Xinjiang province of China.
Methods: A cross-sectional interview-based survey of 5,000 Uyghur women was developed from 2013 to 2014 in
Xinjiang autonomous region, to assess their knowledge and perception of cervical cancer and its issues. The
collection of data was based on the questionnaire items.
Results: According to the questionnaire items, we collected a data for 5,000 participants. A very small proportion of
participants had heard of the cervical cancer, human papillomavirus (HPV), and HPV vaccine, that is, 27.0%, 13.0% and,
6.0%, respectively. According to the demographic characteristics, women aged 31 to 40 years were more aware of the
knowledge of cervical cancer (32.9%), HPV (17.8%), and HPV vaccine (9.1%), and women with undergraduate or higher
educational level had more knowledge of cervical cancer (30.0%), HPV (21.0%), and HPV vaccine (9.7%).
Conclusions: From our study, we concluded that Uyghur women need more information about cervical cancer and its
risk factors. Lack of the related knowledge about cervical cancer may be one of the important factors for high
incidence rate of cervical cancer in Uyghur population. In order to reduce the incidence rate and mortality of cervical
cancer in Uyghur women and to make extensive health education to raise awareness of cervical cancer and HPV is
strongly needed than prophylactic vaccination.
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Cervical cancer continues to be one of the leading fe-
male genital cancers worldwide. About 80% of cases
occur in developing countries and about 87% cervical
cancer deaths occur in less developed regions [1-3].
China accounts for 29.0% of the 51,000,000 new cases of
cervical cancer each year [4]. In China, there is an an-
nual incidence of about 46,000 cases, and cervical cancer
presents a major health problem [5].
Xinjiang province has the highest incidence (590/
100,000) and mortality rate of cervical cancer in China,* Correspondence: abida0724@126.com
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unless otherwise stated.especially the south of Xinjiang. The incidence of cer-
vical cancer among the Uyghur women is four times
higher than the mean incidence of China (138/100,000)
[6,7]. The prevalence of cervical cancer in Uyghur
women has been remarkably higher than the ethnic
groups living in the same region, and the mortality rate
was more than the other ethnic minorities in China.
Epidemiologic evidence clearly indicates that high-risk
human papillomavirus (HPV) is the principal cause of
invasive cervical cancer and cervical intraepithelial neo-
plasia (CIN). Invasive cervical cancer is attributed to
HPV infection. Seventy percent of the cancers are known
to be caused by HPV 16 or 18 [8].
According to our previous study, HPV 16 was the most
common type detected in Uyghur women with squamousentral. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Abudukadeer et al. World Journal of Surgical Oncology  (2015) 13:110 Page 2 of 7cell carcinoma and CIN in Xinjiang. The prevalence of
HPV 18 and 58 was relatively low, and all other types were
absent. Together with the high infection rate, this may be
the reason for the fourfold higher cervical cancer inci-
dence in this province and in this population [9].
Cervical cancer is a deadly disease once it reaches the
invasive stages, but out of all the female genital tract
cancers, it is the only preventable cancer if detected at
its early stages [10]. Therefore, the key to reducing can-
cer morbidity and mortality is still the early detection
and treatment of pre-cancerous lesions.
Cervical cancer can be effectively controlled through
primary and secondary prevention such as, cervical
screening and prophylactic HPV vaccination. Since the
Pap smear test was introduced for routine screening, a
substantial decline has been witnessed in cervical cancer
deaths in developed countries in the last four decades [11].
It is a general consensus that the cytology screening
for cervical cancer is effective in reducing the incidence
and mortality in developed countries. In contrast to this
striking result, cervical cancer is the second most com-
mon cancer among women and the leading cause of
cancer death in developing countries due to inadequate
use of the screening service.
HPV vaccines are expected to effectively avert cervical
morbidity and mortality in China, if it was routinely
used in women. But because of the limitations of
prophylactic HPV vaccination, it is imposing a substan-
tial burden to the women health in the developing coun-
tries. Therefore, evaluate the awareness and knowledge
of screening for cervical cancer among the high risk
people and to make good education program is vital to
reduce the incidence of cervical cancer in developing
countries. Various studies have been undertaken to
evaluate women’s awareness and knowledge of cervical
cancer and screening for cervical cancer [12-14].
With the lack of knowledge about the disease and fa-
miliarity with the concept of prevention, there is no way
to mention early detection of cervical cancer and use of
HPV vaccination.
It is not clear how well HPV and its association to cer-
vical cancer is known in the general population, espe-
cially in Xinjiang.
This study was undertaken to explore the knowledge
of Uyghur women in Xinjiang Autonomous Region,




A cross-sectional study was carried out among the
Uyghur women in Xinjiang province of China. A total of
5,000 women were recruited in our investigation be-
tween 2013 and 2014. The sample population wascomposed of ≤20 years to ≥51 year olds. A questionnaire
with the options of ‘yes’ and ‘no’ for each item was used
for the collection of data. A total of 5,625 questionnaires
were distributed, and out of them, 5,000 participants
responded. The participants were recruited after door-to-
door investigation. Face-to-face interviews were adminis-
tered by the team of doctors from the First Affiliated
Hospital of Xinjiang Medical University, China.
Questionnaire/data collection
The underlying concept and format of the questionnaire
was developed by our review of literature and research
hypotheses. The questionnaire was designed to assess
the knowledge about cervical cancer, HPV, and HPV
vaccine by demographic variables and life style factors.
The questionnaire was modeled in such a manner that
the women could provide answers to the personal ques-
tions in private, without requiring assistance of an
interviewer.
The listed questionnaire items were also mentioned in
Uyghur language to avoid language barrier and to get
better response from the respondents.
Prior to the initiation of the survey, practice interviews
were conducted in order to ensure that the interviews
were undertaken in a standardized manner. The study
design was approved by the Ethics Committee of First
Affiliated Hospital of Xinjiang Medical University.
Data analysis
For statistical analysis, SPSS statistics (version 17.0) was
used. Chi-squared (X2) test was used to examine the dif-
ferences in demographic variables between women with
knowledge about cervical cancer, HPV, and HPV vaccine.
Logistic regression was used with the inclusion of age
and education as the factors in the logistic regression
models. P value of <0.05 was considered statistically
significant.
Results
A total of 5,625 questionnaires were distributed, and out
of them, 5,000 (88.9%) participants responded. The age
of the women ranged from ≤20 years to ≥51 year olds.
Table 1 comprises the questionnaire items showing the
Uyghur women knowledge about cervical cancer and is-
sues related to it.
The women were asked to tell whether or not they
had heard of cervical cancer and then asked to provide
answers of 13 more questions that served to evaluate the
level of cervical cancer and HPV knowledge.
Cervical cancer knowledge
Overall, very less proportion of participants (1,350 (27.0%))
had heard of cervical cancer. Out of them, 475 (35.2%)
responded that they heard of cervical cancer from friends,
Table 1 Uyghur women knowledge and analysis of related
elements of cervical cancer, HPV, and HPV vaccine
Questionnaire items Uyghur women
Number Percentage
Have you heard of cervical cancer?
Yes 1,350 27
No 3,650 73






Do not know 3,650 73.0
Do you know the need of cervical cancer screening once a year?
Yes 1,000 20.0
No 4,000 80.0
Do you know the risk factors of cervical cancer?
Yes 900 18.0
HPV 350 7.0
Having HIV 82 1.64
Smoking 67 1.34
Using birth control pills for a long time
(5 or more years)
42 0.84
Having given birth to three or more
children
64 1.28
Having several sexual partners 104 2.08
Being younger than 17 at first full term
pregnancy
79 1.58
Having a family history of cervical cancer 112 2.24
No 4,100 82.0
Do you want to have regular gynaecological examination?
Yes 900 18.0
No 4,100 82.0
Why you never had regular gynaecological examination?
Because of the economy problem 1,681 41.0
Because of lack of awareness of the
importance of regular gynaecological
examination.
1,804 44.0
Because of lack of time 1,515 30.3
Have you ever had cervical Pap smear test?
Yes 1,650 33.0
No 3,350 67.0
Do you know the significance of cervical Pap smear test?
Yes 1,350 27.0
No 3,650 73.0
Table 1 Uyghur women knowledge and analysis of related
elements of cervical cancer, HPV, and HPV vaccine
(Continued)
Have you heard of HPV?
Yes 650 13.0
No 4,350 87.0
Do you know the link between HPV and cervical cancer?
Yes 350 7.0
No 4,650 93.0
Have you ever had an HPV test before?
Yes 450 9.0
No 4,550 91.0
Have you heard of HPV vaccine?
Yes 300 6.0
No 4,700 94.0
Do you think men could be the risk factor for cervical cancer?
Yes 1,250 25.0
No 3,750 75.0




Abudukadeer et al. World Journal of Surgical Oncology  (2015) 13:110 Page 3 of 7458 (33.9%) responded that they heard of cervical cancer
through television, 117 (8.7%) responded they had heard
of cervical cancer from broadcast, 90 (6.7%) responded
that they got to know about cervical cancer from maga-
zines, 210 (15.5%) of the respondents had heard of it by
other means, whereas 3,650 (73.0%) participants were un-
sure about it. A total of 3,650 (73.0%) participants had
never heard of cervical cancer. As shown in Table 2, at
least 1,385 (27.7%) participants had undergraduate or
higher level of education. Women who had undergraduate
or higher level of education had more awareness of cer-
vical cancer, that is, 30.0% as compared to the women
with lower level of education. So, a significant difference
was found in the educational levels of the participants
with different levels of knowledge about cervical cancer
(P < 0.05).
As shown in Table 3, most of the participants were be-
tween the ages of 31 and 40 years. A total of 1665
(33.3%) participants were ranged between the age group
of 31–40 years. Out of them 549 (32.9%) participants
were aware of cervical cancer. Participants aged ≤20 years
were less that is, 330 (6.6%) participants. And out of them
only 65 (19.7%) participants knew about cervical cancer.
The difference was statistically significant (P < 0.05).
According to the analysis of related elements of cer-
vical cancer, shown in Table 1, the overall knowledge of
the risk factors for cervical cancer was generally poor
with only 900 (18.0%) women knowing at least one of
Table 2 Assessment of Uyghur women knowledge by educational level
Participants Aware of cervical cancer Aware of HPV Aware of HPV vaccine
Number Percentage Number Percentage Number Percentage Number Percentage
Illiteracy 315 6.3 53 16.8 12 3.8 7 2.2
Primary education 1,000 20.0 247 24.9 71 7.1 35 3.6
Secondary education 1,085 21.7 285 26.3 102 9.4 49 4.5
Specialist/professional education 1,215 24.3 349 28.7 173 14.3 74 6.1
Undergraduate or higher education 1,385 27.7 416 30.0 292 21.0 135 9.7
P value P = 0.000 P = 0.000 P = 0.000
Linear-by-linear association has been used; the difference was statistically significant P < 0.05. With the increase of educational level, awareness has increased.
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swered affirmatively that HIV could be one of the risk
factors of cervical cancer, 67 (1.34%) participants an-
swered affirmatively for smoking as a risk factor, 42
(0.84%) participants knew that using birth control pills
for a long time could be a risk factor for cervical cancer,
64 (1.28%) participants answered ‘yes’ for having given
birth to three or more children and, 79 (1.58%) partici-
pants answered ‘yes’ for being younger than 17 at first
term pregnancy as a risk factor for cervical cancer. Most
of the participants answered affirmatively for HPV, hav-
ing several sexual partners and, having a family history
of cervical cancer, that is, 350 (7.0%) participants, 104
(2.08%) participants, and 112 (2.24%) participants, re-
spectively, whereas majority of the study population
(4,100 (82.0%)) were unaware of the risk factors of cer-
vical cancer, and only 1,250 (25.0%) participants had an
idea that males could be the risk factor for cervical can-
cer. Next, we asked some general questions regarding all
the possible reasons for women that ‘Do you want to have
regular gynaecological examination?’ Only 900 (18.0%)
participants answered affirmatively, whereas 4,100 (82.0%)
participants refused to have regular gynaecological exam-
ination. Furthermore, we asked ‘why they never had regu-
lar gynaecological examination?’ Of the participants, 1,804
(44.0%) answered that they were unaware of the import-
ance of regular gynaecological examination, 1,681 (41.0%)
participants answered that they had financial problems,
and 1,515 (30.3%) participants answered that they were
having lack of time. Of the study population, 1,650Table 3 Assessment of Uyghur women knowledge according
Group Participants Aware of cervical canc
Number Percentage Number Percen
≤20 years 330 6.6 65 19.7
21 to 30 years 1,330 26.6 317 23.8
31 to 40 years 1,665 33.3 549 32.9
41 to 50 years 1,165 23.3 302 25.9
≥51 years 510 10.2 117 22.9
P value P = 0.000
Chi-squared (X2) test has been used; the difference was statistically significant when(33.0%) had and 3,350 (67.0%) had not previously under-
gone Pap smear tests, and 1,350 (27.0%) women knew the
significance of cervical Pap smear tests, whereas 3,650
(73.0%) women were unaware of the significance of cer-
vical Pap smear tests. Among the respondents, only 1,000
(20.0%) women had the awareness of the need of cervical
cancer screening once a year, whereas 4,000 (80.0%)
women had no awareness of its need.
HPV knowledge
Overall, only 650 (13.0%) of the participants answered
that they had awareness of HPV and out of them 292
(21.0%) participants had undergraduate or higher educa-
tional level (Table 2). A large number of the participants,
that is, 4,350 (87.0%) participants were totally unaware
of HPV. A statistically significant difference was found
among the educational levels of the participants with dif-
ferent levels of knowledge of HPV (P < 0.05).
As shown in Table 3, according to the different age
group women knowledge about HPV, overall 650 (13.0%)
women knew about HPV. Most of the participants were
between the age of 31 and 40 years. Out of the 1,665
(33.3%) participants between the age group of 31 to
40 years, 297 (17.8%) participants knew about HPV. A sta-
tistically significant difference (P < 0.05) was identified in
age groups relative to the women with different know-
ledge levels of HPV. Furthermore, only 350 (7.0%) partici-
pants knew the link between HPV and cervical cancer,
whereas 4,650 (93.0%) participants had no idea about it.
Four hundred fifty (9.0%) participants had and 4,550to the age group
er Aware of HPV Aware of HPV vaccine
tage Number Percentage Number Percentage
11 3.3 8 2.4
123 9.2 72 5.4
297 17.8 152 9.1
170 14.6 46 3.9
49 9.6 22 4.3
P = 0.000 P = 0.000
P < 0.05.
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test.Knowledge of HPV vaccine
Overall, only 300 (6.0%) participants had heard of HPV
vaccine, whereas 4,700 (90.0%) had never heard of HPV
vaccine (Table 1).
According to Table 2, 1,385(27.7%) participants had
undergraduate or higher levels of education, which was
more than the women who had lower educational level.
Only 290 (6.0%) participants had an affirmative answer
about their knowledge of HPV vaccine. Participants with
undergraduate or higher level of education had more
awareness of HPV vaccine, that is, 135 (9.7%). A statisti-
cally significant difference was identified among the dif-
ferent educational levels of the women with different
knowledge levels about HPV vaccine.
As previously mentioned that most of the participants
were between the age of 31 and 40 years (Table 3), 152
(9.1%) participants between this age group had more
knowledge of HPV vaccine. The difference was statisti-
cally significant (P < 0.05).Discussion
To our knowledge, this is the largest study that has indi-
cated the awareness of cervical cancer screening and HPV
among Uyghur women in Xinjiang, a high-incidence re-
gion of cervical cancer in China. Lack of knowledge about
cervical cancer and Pap smear, certain demographic fac-
tors and unfavourable attitude towards Pap smear test
can have negative impact on utilization of the test by
women. On the other hand, cervical cancer preventive
programs can be effective in increasing cervical cancer
knowledge, perceived susceptibility, and cancer preven-
tion behaviour [15].
A cross-sectional study was carried out among the
5,000 Uyghur women in Xinjiang Uyghur Autonomous
region, China. The purpose was to evaluate their know-
ledge regarding cervical cancer, HPV and HPV vaccine.
The resultant of this survey was that less than a quarter
of the respondents were not at all or very less aware of
cervical cancer, HPV, and HPV vaccine.
As foreseeable, awareness was lower in women with
lower educational levels. With the increase of educa-
tional level, awareness has increased. Earlier studies have
shown important association between health behaviour
and educational level [16]. Low literacy is associated
with low income and poor health status. Cervical cancer
mortality rate is markedly higher among illiterate women.
Interventions aimed at improving health literacy may re-
sult in more functional interaction with the healthcare sys-
tem and less anxiety related to illness, and it may affect
the health patterns of a woman’s family members [17].Developed countries are far ahead because of both or-
ganized and opportunistic Pap screening programs.
Screening rate and Pap smear coverage are 88% and
93%, respectively, in the USA [18,19]. Cervical cancer
screening rate is 63.9% in South Korea, while 7% in rural
India [20], 9.8% in South Africa [21], 17.2% in Sri Lanka
[22], 27.1% in Iran [23], and 45.2% in South Turkey [24].
Since the Papanicolaou (Pap) smear test was intro-
duced for routine screening, a substantial decline has
been witnessed in cervical cancer deaths in developed
countries in the last four decades [25].
A recent survey in Nepal found that only 15.7% of the
participants had utilized cervical Pap smear test in the
past [26] which is lower than that reported in our sur-
vey. In the current study, 33.0% of the participants
responded that they had utilized cervical Pap smear test
in the past and the knowledge about the need of cancer
screening once a year was present only in 20.0% of the
respondents. Women’s attitude and practices towards
screening were negative. Our survey suggests a strong
need to raise public awareness about cervical cancer
screening.
Because of the limitations of prophylactic vaccination
especially in developing countries, cervical screening test
is still a very effective and useful method for reducing high
incidence and mortality of cervical cancer in Xinjiang.
In developed countries, cervical screening programs
have reduced the incidence of invasive cervical cancer
up to 80.0% although this decline has now reached a
plateau with current cancers occurring in patients who
have failed to attend for screening or where the sensitiv-
ity of the tests have proven inadequate.
It is known that precancerous lesions are detectable
for a few years or more before cancer develops. If our
people have related knowledge and health conception
about cervical cancer screening, then this is a long
enough golden period and good opportunity to screen
and prevent this disease.
In order to control or reduce high incidence of cervical
cancer, elevation of knowledge level about cervical cancer
is more important than prophylactic vaccination in
Xinjiang. It was an important task and project on the pre-
vention and to control the incidence of cervical cancer.
The comparison of the findings of the current study
with the other recent surveys is shown in Table 4.
Table 4 clearly shows that the rates reported in our
survey are remarkably lower than the previous surveys.
Low levels of knowledge were also reported in a survey
[27] that only 19.0% of adult Korean women knew that
HPV infection was a risk factor for cervical cancer. Yet,
in another study among Chinese women [28], it was
found that only 26.9% of the respondents knew that
HPV infections were risk factors for cervical cancer. The
findings of all these studies showed that women lacked
Table 4 Comparison of the current study results with the other recent surveys regarding cervical cancer knowledge
Basu P [32] Pan XF [33] Montgomery MP [34] Current
study
Aware of cervical cancer 38.0% 15.0% 27.0%
Aware of HPV 77.9% 36.0% 13.0%
Aware of HPV vaccine 5.5% 29.0% 26.0% 6.0%
Aware of the link between HPV and cervical cancer 28.0% 7.0%
Aware of Pap smear test 18.4% 7.0% 27.0%
Had Pap smear test in the past 33.6% 33.0%
Aware of multiple pregnancies as a risk factor for cervical cancer 12.6% 1.28%
Aware of multiple sex partners as a risk factor for cervical cancer 25.8% 33.0% 2.08%
Aware of the prevention of sexually transmitted diseases prevention by condoms. 60.0% 28.0%
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In comparison to all these studies, the current study
showed relatively low levels of awareness among Uyghur
women.
Similar low levels of knowledge regarding cervical can-
cer in the general population have also been seen in
other Asian countries where there are no cervical cancer
screening programs [29].
A recent survey conducted in Mangalore, India, re-
ported that women who were between the age group of
35 to 40 years had more knowledge of cervical cancer
and issues related to it [30]. This is similar to our survey
that reported that the women between the age group of
31 to 40 years had more awareness of cervical cancer.
The knowledge improved significantly with improve-
ment in the level of education. Several research studies
have shown that health education through different
teaching strategies is an effective way of imparting
knowledge. Education is needed to prevent the incidence
of cervical cancer [31,32]. The education programs are
very effective in increasing cervical cancer knowledge,
perceived susceptibility, and cancer prevention behav-
iours [15]. By education, women can be empowered with
knowledge of cervical cancer, its early warning symp-
toms and the availability of adequate therapies [30].
A recent study conducted in Maldives reported that
the exposure of the women of Maldives to the risk fac-
tors of cervical cancer is high, and the awareness about
cervical cancer, its risk factors, and the methods of pre-
vention is very limited [29]. Our survey reported the
same results that despite of relatively higher incidence
rate of cervical cancer in Xinjiang, less than a quarter of
the respondents were not at all or very less aware of cer-
vical cancer, HPV, and HPV vaccine.
We investigated a lowest level of knowledge or aware-
ness, that is, having heard of HPV, lack of knowledge
about cervical cancer, HPV infection, and its possible
consequences are great impediment for reducing inci-
dence of cervical cancer in high incidence area, Xinjiang.The current national policy of providing mandatory
free education to all the Uyghur women is likely to have
a major impact. Thus, health literacy programs which
are effective not only in increasing knowledge but also
in creating a positive attitude among women towards
Pap smear test should be organized to increase Pap
smear coverage in Xinjiang.Conclusions
Overall, the study results indicated that Uyghur women’s
awareness or level of knowledge and attitude regarding
cervical cancer, HPV, and HPV vaccine is way too low
and unsatisfactory. In order to control or reduce high in-
cidence of cervical cancer, elevation of knowledge level
about cervical cancer is more important than prophylac-
tic vaccination in Xinjiang. Healthcare services should
take serious measures to educate women about cervical
cancer, HPV, and the potential value of HPV vaccination.
Our data highly suggested that educational programs are
needed to prevent the incidence of cervical cancer among
Uyghur women of Xinjiang, a high-incidence region of
cervical cancer in China. Otherwise, it will continue to be
a grave health problem in Xinjiang.
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